Skip to main content
Top
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Screening and its effect on breast cancer mortality rates

Author: RG Blanks

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

In the Health of the Nation document published by the Department of Health in 1993 it was stated that the eventual success of the breast screening programme would be measured in terms of the breast cancer mortality reduction achieved. Unfortunately, outside the environment of randomised controlled trials the actual mortality reduction from screening is extremely difficult to measure with any precision. This is because national mortality statistics between the start of screening in 1988 and the present day have been affected not only by screening, but also by treatment improvements, cohort effects, earlier presentation outside the screening programme and even changes in the way breast cancer deaths are coded. …
Metadata
Title
Screening and its effect on breast cancer mortality rates
Author
RG Blanks
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr198

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

Lymph node diagnosis

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine